I am an experienced medicinal chemist with success at every stage of drug discovery, from lead identification and lead optimization to candidate recommendation, preclinical development and commercialization. I played a key role in programs that delivered seven clinical candidates. I am a co-inventor of the cholesterol absorption inhibitor ezetimibe, which is now marketed as Zetia in the US and is a key component of Vytorin for treating hyperlipidemia. I have led teams of up to 24 chemists (including direct line supervision of 11 chemists) on multiple discovery projects, and maintained high productivity and morale of all team members. I have demonstrated strong team-building skills in interdisciplinary team interactions, and outstanding written and oral communication skills. My career goal is to provide leadership to multiple chemistry discovery teams to discover novel agents to treat human disease.